Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-22

Clinical Trial Update: Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ropivacaine infiltration around the palatine ganglion region to reduce postoperative pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropivacaine (Ropivacaine)

Snippet

Sponsor: University Hospital, Lille | Conditions: Pain | Phase 3 | Status: COMPLETED